Search Results

Clozapine N-oxide, compound 21, and JHU37160 do not influence effortful reward-seeking behavior in mice.

• Authors : Aomine Y; Laboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.; Department of Biological Sciences, Graduate School of Science, Osaka University, Toyonaka, Osaka, Japan.

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacology ; Designer Drugs*/Designer Drugs*/Designer Drugs*/pharmacology; Mice

• Source: Psychopharmacology [Psychopharmacology (Berl)] 2024 Jan; Vol. 241 (1), pp. 89-96. Date of Electronic Publication: 2023 Oct 04.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Insights into the Silylation of Benzodiazepines Using N , O -Bis(trimethylsilyl)trifluoroacetamide (BSTFA): In Search of Optimal Conditions for Forensic Analysis by GC-MS.

• Authors : Vargas Mena, Eleazar¹ (AUTHOR) ; Herrera Giraldo, Eliana R.² (AUTHOR) ; Gómez Castaño, Jovanny A.² (AUTHOR)

Subjects: *GAS chromatography/Mass spectrometry (GC-MS); *PSYCHIATRIC drugs; *PRINCIPAL components analysis

• Source: Molecules. Dec2024, Vol. 29 Issue 24, p5884. 20p.

Record details

Inhibition of RtTg neurons reverses methamphetamine-induced attention deficits.

• Authors : Qu, Xiaotian^1,2 (AUTHOR); Yang, Pingyuan³ (AUTHOR); Zhai, Rongwei⁴ (AUTHOR)

• Source: Acta Neuropathologica Communications. 11/22/2024, Vol. 12 Issue 1, p1-15. 15p.

Record details

Hallucinating hallucinogens.

• Authors : Skinnider MA; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA.

Subjects: Artificial Intelligence* ; Designer Drugs*/Designer Drugs*/Designer Drugs*/chemistry ; Designer Drugs*/Designer Drugs*/Designer Drugs*/toxicity

• Source: Science (New York, N.Y.) [Science] 2023 Nov 10; Vol. 382 (6671), pp. 656-657. Date of Electronic Publication: 2023 Nov 09.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic

Record details

Forensic Aspects of Designer LSD Analogs Identification by GC-MS (EI) and UV Spectroscopy.

• Authors : Tusiewicz K; Institute of Toxicology Research, 45 Kasztanowa Street, 55-093 Borowa, Poland.; Wachełko O

Subjects: Gas Chromatography-Mass Spectrometry*/Gas Chromatography-Mass Spectrometry*/Gas Chromatography-Mass Spectrometry*/methods ; Lysergic Acid Diethylamide*/Lysergic Acid Diethylamide*/Lysergic Acid Diethylamide*/analogs & derivatives ; Lysergic Acid Diethylamide*/Lysergic Acid Diethylamide*/Lysergic Acid Diethylamide*/chemistry

• Source: Molecules (Basel, Switzerland) [Molecules] 2024 Dec 04; Vol. 29 (23). Date of Electronic Publication: 2024 Dec 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Flualprazolam and flubromazolam: Blood concentrations and prevalence of two novel psychoactive substances in forensic case work in Ontario, Canada.

• Authors : Vekic N; University of Toronto, 3359 Mississauga Rd., Mississauga, ON L5L 1C6, Canada.; Armstrong-Price D

Subjects: Designer Drugs*; Humans ; Ontario

• Source: Journal of analytical toxicology [J Anal Toxicol] 2023 Nov 01; Vol. 47 (8), pp. 762-769.Publisher: Oxford University Press Country of Publication: England NLM ID: 7705085 Publication Model: Print Cited Medium: Internet ISSN:

Record details

A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition.

• Authors : Lawson KA; Department of Neurobiology and Behavior, University of California Irvine, 1132 McGaugh Hall, Irvine, CA, 92697, USA. .; Ruiz CM

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacology ; Designer Drugs*; Rats

• Source: Psychopharmacology [Psychopharmacology (Berl)] 2023 Oct; Vol. 240 (10), pp. 2101-2110. Date of Electronic Publication: 2023 Aug 02.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7608025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson's disease.

• Authors : Wang, Xueyao^1,2,3 (AUTHOR); Han, Deqiang^1,2,3 (AUTHOR) ; Zheng, Tianqi¹ (AUTHOR)

• Source: Stem Cell Research & Therapy. 9/11/2024, Vol. 15 Issue 1, p1-14. 14p.

Record details

In Silico Screening of Therapeutic Targets as a Tool to Optimize the Development of Drugs and Nutraceuticals in the Treatment of Diabetes mellitus : A Systematic Review.

• Authors : Gomes, Ana Francisca T.¹ (NURSE) ; de Medeiros, Wendjilla F.¹ (NURSE) ; Medeiros, Isaiane² (NURSE)

Subjects: *DRUG development; *MOLECULAR dynamics; *DRUG target

• Source: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9213. 15p.

Record details

Assessing Popper Purity—Implications for the Regulation and Recreational Use of Alkyl Nitrites.

• Authors : Makarewicz, Nathan S.¹ (AUTHOR) ; Albertson, Brent G.² (AUTHOR); Sia, Twan³ (AUTHOR)

• Source: Psychoactives. Sep2024, Vol. 3 Issue 3, p400-410. 11p.

Record details